Grants and Contributions:
Title:
Optimization of the Transdermal Agent Concentration in a Topical THC/CBD Infused Gel
Agreement Number:
1036303
Agreement Value:
$48,180.00
Agreement Date:
Oct 1, 2025 - Aug 31, 2027
Description:
Remidose plans to optimize the concentration of the transdermal agent in its topical THC/CBD infused gel.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Stratford, Prince Edward Island, CA C1B 2W2
Reference Number:
172-2025-2026-Q3-1036303
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
720359736
Recipient Type:
For-profit organization
Recipient's Operating Name:
Remidose
Recipient's Legal Name:
Remidose Aerosols Inc.
Federal Riding Name:
Cardigan
Federal Riding Number:
11001
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710